AZ gets rights to two of Nektar's candidates
Drug delivery company Nektar Therapeutics has granted AstraZeneca exclusive worldwide development, manufacturing, and commercialization rights to two drug candidates for opioid-induced constipation (OIC) and pain.
- Drug Delivery
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com